Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

Al-Mamgani A, van Putten WL, Heemsbergen WD, van Leenders GJ, Slot A, Dielwart MF, Incrocci L, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):980-8. doi: 10.1016/j.ijrobp.2008.02.073. Epub 2008 May 19.

PMID:
18495377
2.

Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer.

Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):67-74. Epub 2007 Aug 31.

PMID:
17765406
3.

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial.

Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA, Huddart RA, Jose CC, Matthews JH, Millar J, Moore AR, Morgan RC, Russell JM, Scrase CD, Stephens RJ, Syndikus I, Parmar MK; RT01 collaborators.

Lancet Oncol. 2007 Jun;8(6):475-87.

PMID:
17482880
4.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, Sandler H.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74.

PMID:
16798415
5.

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, Shipley WU.

JAMA. 2005 Sep 14;294(10):1233-9. Erratum in: JAMA. 2008 Feb 27;299(8):899-900.

PMID:
16160131
6.

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR; CaPSURE Investigators.

J Urol. 2004 Apr;171(4):1393-401. Review.

7.

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):25-33.

PMID:
14697417
8.
9.

Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era.

D'Amico AV, Chen MH, Oh-Ung J, Renshaw AA, Cote K, Loffredo M, Richie JP.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):436-41.

PMID:
12243819
10.
11.

The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer.

Vicini FA, Kestin LL, Martinez AA.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):553-61.

PMID:
10524405
12.

Conformal proton therapy for prostate carcinoma.

Slater JD, Yonemoto LT, Rossi CJ Jr, Reyes-Molyneux NJ, Bush DA, Antoine JE, Loredo LN, Schulte RW, Teichman SL, Slater JM.

Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):299-304.

PMID:
9788407
13.

Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel.

[No authors listed]

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1035-41. No abstract available.

PMID:
9169810
15.

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.

Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, Young RH, Shipley JW, Zietman AL, Biggs PJ, et al.

Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):3-12.

PMID:
7721636
16.

Evaluation of survival data and two new rank order statistics arising in its consideration.

Mantel N.

Cancer Chemother Rep. 1966 Mar;50(3):163-70. No abstract available.

PMID:
5910392
17.

Study duration for clinical trials with survival response and early stopping rule.

Kim K, Tsiatis AA.

Biometrics. 1990 Mar;46(1):81-92.

PMID:
2350572
18.

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, Cox JD, Perez CA, Sause WT, Doggett SR, et al.

Int J Radiat Oncol Biol Phys. 1991 Sep;21(4):935-9.

PMID:
1917622
19.

Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels.

Dugan TC, Shipley WU, Young RH, Verhey LJ, Althausen AF, Heney NM, McManus PL, Abraham EH.

J Urol. 1991 Nov;146(5):1313-6.

PMID:
1719244
20.

Proton radiation as boost therapy for localized prostatic carcinoma.

Shipley WU, Tepper JE, Prout GR Jr, Verhey LJ, Mendiondo OA, Goitein M, Koehler AM, Suit HD.

JAMA. 1979 May 4;241(18):1912-5.

PMID:
107338

Supplemental Content

Support Center